Direct Hospital Cost Determinants Following Hip and Knee Arthroplasty
- 25 May 2015
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 67 (6), 782-790
- https://doi.org/10.1002/acr.22523
Abstract
Total joint arthroplasty (TJA) places a significant economic burden on health care resources. This cohort study examines the costs associated with arthroplasty in 827 patients undergoing hip and knee TJA from January 2011 to June 2012 at a single center in Melbourne, Australia. Data included total inpatient, outpatient, and readmissions costs in the 30 days following TJA. Factors associated with cost were modeled using negative binomial regression and extrapolated to the Australian population. The base cost (i.e., the cost for a patient with no modifying factors) over the first 30 days following TJA was $13,060 Australian (AU) (interquartile range $12,126–14,067 AU). The median length of stay was 4 days (range 2–33 days) and 35 patients (4%) were readmitted in the first 30 days following index TJA, the majority of whom had a surgical site infection (SSI) (74%). The following factors were independently associated with increased costs: SSI, preoperative warfarin therapy, American Society of Anesthesiologists score of 3 or 4, hip TJA, increasing operation time, increasing postoperative blood transfusion requirements, other nosocomial infections, postoperative venous thromboembolism (VTE), pressure ulcers, postoperative confusion, and acute urinary retention. Based on data from the present study, the cost of TJA in Australia is estimated to exceed $1 billion AU per year. Preventable postoperative complications were major cost drivers: SSI and VTE added a further $97 million AU and $66 million AU, respectively, to arthroplasty costs in the first 30 days following surgery. This unique study has identified important factors influencing TJA costs and providing guidance for future research and resource allocation.Funding Information
- National Health and Medical Research Council (NHMRC) (APP1057736)
- NHMRC Early Career Australian Clinical Fellowship (APP1069374, APP1035810)
- NHMRC Career Development Fellowship 2 (APP1068732)
This publication has 23 references indexed in Scilit:
- Risk factors for superficial wound complications in hip and knee arthroplastyClinical Microbiology & Infection, 2014
- Lifetime Risk of Total Hip Replacement Surgery and Temporal Trends in Utilization: A Population‐Based AnalysisArthritis Care & Research, 2014
- Bundled Payments in Total Joint Arthroplasty: Targeting Opportunities for Quality Improvement and Cost ReductionClinical Orthopaedics and Related Research, 2014
- Cost analysis of debridement and retention for management of prosthetic joint infectionClinical Microbiology & Infection, 2013
- Determinants of Direct Medical Costs in Primary and Revision Total Knee ArthroplastyClinical Orthopaedics and Related Research, 2013
- Economic Burden of Periprosthetic Joint Infection in the United StatesThe Journal of Arthroplasty, 2012
- The Potential for Cost Savings through Bundled Episode PaymentsThe New England Journal of Medicine, 2012
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Published by Ovid Technologies (Wolters Kluwer Health) ,2007
- Guideline for Prevention of Surgical Site Infection, 1999Infection Control & Hospital Epidemiology, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987